ArticleToxicological sciences : an official journal of the Society of Toxicology2020

Utility of In Vitro Bioactivity as a Lower Bound Estimate of In Vivo Adverse Effect Levels and in Risk-Based Prioritization.

Katie Paul Friedman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.